Skip to main content
. 2014 Aug 15;4(5):426–434.

Table 1.

Demographic data

Author Journal Year No Patients Tumor Lesions Reference
Goel et al IJNM 2014 30 All NET Mets [26]
Armbruster et al JIR 2014 42 All NET Liver Mets [27]
Haug et al Radiology 2013 63 All NET (Excluded MTC) Mets [19]
Schmid et al EJNMMI 2013 18 Pancreatic NET Panc lesions+mets [25]
Haug et al JNM 2012 104 All NET Primary lesions+mets [18]
Maurice et al EJNMMI 2012 15 PCC, PGL Primary lesions+mets [23]
Hofman et al JMIRO 2012 59 NET (GEP, Bronc, PCC, PGL) Primary lesions+mets [12]
Łapińska et al NMRCEE 2011 97 NET (GEP, MCT) Primary lesions+mets [21]
Naji et al MIAB Aug 2010 12 PCC, PGL Primary lesions+mets [24]
Srirajaskanthan et al JNM June 2010 51 All NET Primary lesions+mets [20]
Conry et al EJNMMI 2010 18 MTC Primary lesions+mets [28]
Kayani et al JNM 2009 18 All NET Primary lesions+mets [30]
Kayani et al Cancer 2008 38 All NET Primary lesions+mets [28]
Win et al NMC 2007 5 PCC Mets [22]

NET: Neuroendocrine Tumor, MTC: Medullary Thyroid Cancer, PCC: Pheochromocytoma, PGL: Paraganglioma, GEP: Gastroenteropancreatic, Bronc: Bronchial.

HHS Vulnerability Disclosure